Yara Abdou

1.4k total citations
64 papers, 626 citations indexed

About

Yara Abdou is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yara Abdou has authored 64 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 27 papers in Cancer Research and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yara Abdou's work include Breast Cancer Treatment Studies (20 papers), CAR-T cell therapy research (13 papers) and Cancer Genomics and Diagnostics (11 papers). Yara Abdou is often cited by papers focused on Breast Cancer Treatment Studies (20 papers), CAR-T cell therapy research (13 papers) and Cancer Genomics and Diagnostics (11 papers). Yara Abdou collaborates with scholars based in United States, United Kingdom and India. Yara Abdou's co-authors include Marc S. Ernstoff, Abhay Singh, Rohit Gosain, Navpreet Rana, Igor Puzanov, Kristopher Attwood, Samik Upadhaya, Lisa A. Carey, Kazuaki Takabe and Benjamin G. Vincent and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Yara Abdou

49 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yara Abdou United States 13 415 121 113 101 99 64 626
Enes Erul Türkiye 11 304 0.7× 75 0.6× 155 1.4× 87 0.9× 48 0.5× 34 610
Angelika M. Starzer Austria 13 300 0.7× 117 1.0× 140 1.2× 51 0.5× 75 0.8× 27 482
Celeste Cagnazzo Italy 12 463 1.1× 105 0.9× 137 1.2× 74 0.7× 67 0.7× 56 758
Bradley R. Hall United States 12 244 0.6× 111 0.9× 131 1.2× 70 0.7× 32 0.3× 29 723
Aparna Hegde United States 11 476 1.1× 125 1.0× 147 1.3× 33 0.3× 58 0.6× 31 642
Abdellatif Benider Morocco 16 498 1.2× 52 0.4× 106 0.9× 130 1.3× 41 0.4× 102 906
Zhen Ni Zhou United States 13 398 1.0× 490 4.0× 84 0.7× 98 1.0× 38 0.4× 27 996
John T. Cole United States 10 189 0.5× 62 0.5× 108 1.0× 86 0.9× 33 0.3× 25 613
Yahua Zhong China 15 296 0.7× 44 0.4× 110 1.0× 122 1.2× 54 0.5× 56 622
Valeria Musella Italy 13 139 0.3× 63 0.5× 68 0.6× 202 2.0× 99 1.0× 32 712

Countries citing papers authored by Yara Abdou

Since Specialization
Citations

This map shows the geographic impact of Yara Abdou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yara Abdou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yara Abdou more than expected).

Fields of papers citing papers by Yara Abdou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yara Abdou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yara Abdou. The network helps show where Yara Abdou may publish in the future.

Co-authorship network of co-authors of Yara Abdou

This figure shows the co-authorship network connecting the top 25 collaborators of Yara Abdou. A scholar is included among the top collaborators of Yara Abdou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yara Abdou. Yara Abdou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carey, Lisa A., et al.. (2025). Bridging the gap: ctDNA, genomics, and equity in breast cancer care. npj Breast Cancer. 11(1). 92–92. 1 indexed citations
2.
Thai, Christine, et al.. (2025). Predictors of Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer. Annals of Surgical Oncology. 32(13). 9767–9775.
3.
4.
Abdou, Yara, Prarthna V Bhardwaj, Rachel O. Abelman, et al.. (2024). Abstract PO3-05-14: Practice patterns for sequential use of antibody-drug conjugate after antibody-drug conjugate in metastatic breast cancer: results from a physician survey. Cancer Research. 84(9_Supplement). PO3–5. 1 indexed citations
5.
Jeselsohn, Rinath, Jingxin Fu, Reshma Mahtani, et al.. (2024). Abstract PS12-02: Exploration of ctDNA Dynamics in the PACE Trial: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for HR+/HER2- Metastatic Breast Cancer. Cancer Research. 84(9_Supplement). PS12–2. 1 indexed citations
6.
Abdou, Yara, Paula R. Pohlmann, Richard T. Maziarz, et al.. (2024). A phase 1, first-in-human study of autologous monocytes engineered to express an anti-HER2 chimeric antigen receptor (CAR) in participants with HER2-overexpressing solid tumors.. Journal of Clinical Oncology. 42(16_suppl). TPS2682–TPS2682. 4 indexed citations
7.
Dunn, Matthew R., Alina M. Hamilton, Xiaohua Gao, et al.. (2024). Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status. Cancer Epidemiology Biomarkers & Prevention. 33(5). 654–661. 7 indexed citations
8.
Roy, Arya Mariam, Paola Zagami, Kristopher Attwood, et al.. (2024). Real-World Clinical Outcomes With Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer. JCO Oncology Practice. 21(5). 620–628. 7 indexed citations
9.
Roy, Arya Mariam, et al.. (2024). Abstract PO3-06-10: Real World Outcomes with Sacituzumab Govitecan in Metastatic Triple Negative Breast Cancer Patients: A Multi-Institution Study. Cancer Research. 84(9_Supplement). PO3–6. 1 indexed citations
10.
Mantooth, Siena M., et al.. (2024). Intratumoral delivery of immunotherapy to treat breast cancer: current development in clinical and preclinical studies. Frontiers in Immunology. 15. 1385484–1385484. 12 indexed citations
11.
Carter, Gebra Cuyún, et al.. (2024). Value of next generation sequencing (NGS) testing in advanced cancer patients. Journal of Medical Economics. 27(1). 519–530. 2 indexed citations
12.
Bhardwaj, Prarthna V, et al.. (2023). Advances in the Management of Early-Stage Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 24(15). 12478–12478. 2 indexed citations
13.
Berdunov, Vladislav, et al.. (2023). The budget impact of utilizing the Oncotype DX Breast Recurrence Score test from a US healthcare payer perspective. Journal of Medical Economics. 26(1). 973–990. 1 indexed citations
14.
Bhardwaj, Prarthna V & Yara Abdou. (2023). The Evolving Landscape of Immune Checkpoint Inhibitors and Antibody Drug Conjugates in the Treatment of Early-Stage Breast Cancer. The Oncologist. 28(10). 832–844. 13 indexed citations
15.
Abdou, Yara, E. Claire Dees, Joanne Mortimer, et al.. (2023). Abstract CT241: A phase 1, first-in-human (FIH) study of autologous anti-HER2 chimeric antigen receptor macrophage (CAR-M) in participants (pt) with HER2 overexpressing solid tumors. Cancer Research. 83(8_Supplement). CT241–CT241. 2 indexed citations
16.
Bhardwaj, Prarthna V & Yara Abdou. (2022). Germline Genetic Testing in Breast Cancer: Systemic Therapy Implications. Current Oncology Reports. 24(12). 1791–1800. 4 indexed citations
17.
Abdou, Yara, et al.. (2022). Immunotherapy in triple negative breast cancer: beyond checkpoint inhibitors. npj Breast Cancer. 8(1). 121–121. 69 indexed citations
18.
Abdou, Yara, Kristopher Attwood, Song Yao, et al.. (2020). Racial differences in CD8+ T cell infiltration in breast tumors from Black and White women. Breast Cancer Research. 22(1). 62–62. 32 indexed citations
19.
Abdou, Yara, Ahmed Elkhanany, Kristopher Attwood, et al.. (2019). Primary and secondary breast angiosarcoma: single center report and a meta-analysis. Breast Cancer Research and Treatment. 178(3). 523–533. 57 indexed citations
20.
Abdou, Yara, et al.. (2017). External Validation of the COmorbidity Test. COPD Journal of Chronic Obstructive Pulmonary Disease. 14(5). 513–517. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enes Erul Breakdown of academic impact, for papers by Angelika M. Starzer Breakdown of academic impact, for papers by Celeste Cagnazzo Breakdown of academic impact, for papers by Bradley R. Hall Breakdown of academic impact, for papers by Aparna Hegde Breakdown of academic impact, for papers by Abdellatif Benider Breakdown of academic impact, for papers by Zhen Ni Zhou Breakdown of academic impact, for papers by John T. Cole Breakdown of academic impact, for papers by Yahua Zhong Breakdown of academic impact, for papers by Valeria Musella
Rankless by CCL
2026